Congratulations to Better Therapeutics on Closing Business Combination and Debut on Nasdaq

On October 29, 2021, Better Therapeutics debuted on Nasdaq under the ticker symbol BTTX.

• August 16, 2022

Better Therapeutics, a client company of LS Associates, is a biotech company providing accessible cognitive behavioral therapy. Their mission to treat not only the effects of cardiometabolic diseases, but also the causes, is critical for the millions of people living with diseases such as type 2 diabetes.

In October 2021, Better Therapeutics announced its business combination with Mountain Crest Acquisition Corp II, a publicly traded SPAC. LS Associates came alongside Better Therapeutics in their process of its Business Combinarion.

LS Associates congratulates our friends at Better Therapeutics on their success!

We are a member of the global LifeSci Partner platform that has been providing valuable executive advisory services since 2009.